Myomo, Inc. MYO

Company Overview

Myomo, Inc. is a U.S.-based medical robotics and wearable medical technology company focused on developing powered orthotic devices intended to improve arm and hand function for individuals with neurological disorders and upper-limb paralysis. The company operates within the medical device, rehabilitation technology, and neuro-robotics industries. Its primary product line is the MyoPro orthosis, a wearable powered brace designed to detect weak electromyography (EMG) signals from a patient’s muscles and assist movement of the elbow, wrist, and hand. Revenue is primarily generated through sales and reimbursement-supported distribution of these devices to patients, healthcare providers, and rehabilitation networks.

The company serves individuals affected by stroke, brachial plexus injury, spinal cord injury, multiple sclerosis, and other neuromuscular conditions. Myomo’s strategic positioning is centered on proprietary myoelectric control technology that enables users with limited muscular activity to regain functional movement. Originally developed from research conducted at the Massachusetts Institute of Technology (MIT), the company commercialized its technology during the mid-2000s and later became publicly traded through a reverse merger transaction. Public disclosures in SEC filings and investor materials indicate that Myomo has increasingly focused on direct billing, reimbursement support, and patient acquisition infrastructure to expand adoption of the MyoPro platform.